FDA issues quarterly list of drugs under safety investigation

10/7/2009 | Reuters

The FDA released its quarterly list of drugs under review for potential safety issues. Included are Pfizer's cancer treatment Sutent, Wyeth and Progenics Pharmaceuticals' constipation drug Relistor, and Medicis Pharmaceutical's antibiotic Solodyn. The agency reiterated that appearance on the list "does not mean that FDA has identified a causal relationship between the drug and the listed risk."

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR CLINICAL RESEARCH - 14000003MB
Abbott
Santa Clara, CA
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA